title: Should cotrimoxazole prophylaxis be taken by all adults with HIV in Africa?
authors.forename: Jonathan
authors.initials: J
authors.lastname: Mermin
authors.forename: John R
authors.initials: JR
authors.lastname: Lule
authors.forename: John P
authors.initials: JP
authors.lastname: Ekwaru
authors.forename: Christian
authors.initials: C
authors.lastname: Pitter
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D000349:Africa; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003906:Developing Countries; D006801:Humans; D018579:Patient Selection; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination